Three months therapy with ranitidine bismuth citrate (RBC) reduces H-pylori-associated gastritis and density of H-pylori but does not cure the infection.

被引：0
|
作者：
Graham, DY
Walsh, JH
Schubert, TT
Lanza, FL
Peura, DA
Peterson, W
Riff, DS
Yardley, J
Ciociola, AA
Kong, S
Wood, D
Webb, DD
机构：
[1] VET ADM MED CTR, HOUSTON, TX 77211 USA
[2] CURE, LOS ANGELES, CA USA
[3] DIGEST CONSULTANTS, TACOMA, WA USA
[4] INST CLIN RES, HOUSTON, TX USA
[5] UNIV VIRGINIA, CHARLOTTESVILLE, VA 22903 USA
[6] VET ADM MED CTR, DALLAS, TX 75216 USA
[7] GASTROENTEROL GRP, ANAHEIM, CA USA
[8] JOHNS HOPKINS MED CTR, BALTIMORE, MD USA
[9] GLAXO WELLCOME INC, RES TRIANGLE PK, NC USA
来源：
GASTROENTEROLOGY | 1996年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A122 / A122
页数：1
相关论文
共 50 条
  • [1] Metronidazole resistance does not influence the efficacy of triple therapy with ranitidine bismuth citrate (RBC), clarithromycin (CLA) and metronidazole (MET) for H-pylori (Hp) infection.
    van der Wouden, EJ
    Thijs, JC
    van Zwet, AA
    Kooy, A
    Kleibeuker, JH
    GASTROENTEROLOGY, 1998, 114 (04) : A323 - A323
  • [2] A prospective randomized trial of one-week bismuth ranitidine citrate (RBC) triple therapies for H-pylori infection.
    Sung, JJY
    Chan, FKL
    Leung, WK
    Wu, JCY
    Suen, R
    Ling, TKW
    Lee, YT
    Cheng, AFB
    Chung, SCS
    GASTROENTEROLOGY, 1999, 116 (04) : A321 - A321
  • [3] Prospective randomized comparisons of ranitidine bismuth citrate (RBC) versus colloidal bismuth subcitrate (Denol)-based triple therapy for the treatment of H-pylori infection.
    Kung, NNS
    Sung, JY
    Yuen, WF
    Li, TH
    Ng, PW
    Lai, WM
    Leung, MF
    GASTROENTEROLOGY, 1998, 114 (04) : A190 - A190
  • [4] Randomized comparison of ranitidine bismuth citrate (RBC)-based triple therapies for H-pylori
    Laine, L
    Estrada, R
    Trujillo, M
    Emami, S
    GUT, 1997, 41 : A103 - A104
  • [5] Randomized comparison of ranitidine bismuth citrate (RBC)-based triple therapies for H-pylori (HP).
    Laine, L
    Estrada, R
    Trujillo, M
    Emami, S
    GASTROENTEROLOGY, 1997, 112 (04) : A192 - A192
  • [6] The influence of cure of H-pylori infection on the long term sequelae of H-pylori gastritis.
    vanderHulst, RWM
    Koycu, B
    Rauws, EAJ
    Dekker, FW
    Tytgat, GNJ
    tenKate, FJW
    GASTROENTEROLOGY, 1997, 112 (04) : A320 - A320
  • [7] One-week therapy of ranitidine bismuth citrate (RBC) with different combinations of antimicrobial for H-pylori infection:: Which is the best regimen?
    Sung, JY
    Chan, FKL
    Leung, WK
    Wu, JCY
    Suen, R
    Ling, TKW
    Cheng, AFB
    Chung, SCS
    GUT, 1998, 43 : A81 - A81
  • [8] The influence of metronidazole (MET) resistance on the efficacy of two triple therapy regimens with ranitidine bismuth citrate (RBC) for H-pylori (Hp) infection
    Van der Wouden, EJ
    Thijs, JC
    van Zwet, AA
    Kooy, A
    Kleibeuker, JH
    GUT, 1998, 43 : A86 - A86
  • [9] Ranitidine bismuth citrate (RBC) and azithromycin with or without amoxicillin in the eradication of H-pylori in patients with peptic ulcer
    Katicic, M
    Duvnjak, M
    Vucelic, B
    Krizman, I
    Pavic-Sladoljev, D
    Culig, J
    Naletilic, D
    GUT, 1999, 45 : A115 - A115
  • [10] Rescue therapy with ranitiefine bismuth citrate (RBC) after H-pylori treatment failure
    Gisbert, JP
    Fuentes, J
    Carpio, D
    Tito, L
    Guardiola, J
    Tomas, A
    Calvet, X
    GASTROENTEROLOGY, 2005, 128 (04) : A427 - A427
12345